RSCM
Rock Springs Capital Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.54M | Sell |
221,500
-754,303
| -77% | -$12.1M | 0.22% | 69 |
|
|
2025
Q1 | $16.7M | Buy |
975,803
+66,700
| +7% | +$1.14M | 0.95% | 38 |
|
|
2024
Q4 | $22.5M | Sell |
909,103
-312,206
| -26% | -$7.73M | 0.86% | 42 |
|
|
2024
Q3 | $34.8M | Buy |
1,221,309
+35,655
| +3% | +$1.02M | 1.13% | 36 |
|
|
2024
Q2 | $31.3M | Buy |
1,185,654
+35,531
| +3% | +$938K | 0.94% | 41 |
|
|
2024
Q1 | $37.2M | Buy |
1,150,123
+166,822
| +17% | +$5.39M | 0.94% | 38 |
|
|
2023
Q4 | $41.4M | Buy |
983,301
+338,957
| +53% | +$14.3M | 1.02% | 34 |
|
|
2023
Q3 | $24.7M | Buy |
+644,344
| New | +$24.7M | 0.66% | 50 |
|
|
2021
Q1 | – | Sell |
-891,000
| Closed | -$41.2M | – | 159 |
|
|
2020
Q4 | $41.2M | Buy |
891,000
+148,551
| +20% | +$6.86M | 0.87% | 39 |
|
|
2020
Q3 | $26.1M | Buy |
742,449
+290,130
| +64% | +$10.2M | 0.66% | 48 |
|
|
2020
Q2 | $11M | Buy |
452,319
+202,319
| +81% | +$4.93M | 0.3% | 99 |
|
|
2020
Q1 | $3.89M | Buy |
+250,000
| New | +$3.89M | 0.16% | 108 |
|